Last news
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment

JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment

Notified -...

CAPHRA warns WHO against one-size-fits-all nicotine pouch restrictions

CAPHRA warns WHO against one-size-fits-all nicotine pouch restrictions

Notified -...

CGTN: Head-of-state diplomacy anchors growing China-Russia partnership

CGTN: Head-of-state diplomacy anchors growing China-Russia partnership

Notified -...

Countdown Grant Explores How Cells Remove Damaged Mitochondria — Opening New Possibilities Across Parkinson’s, Chronic Disease, Rare Disease, and Aging

Countdown Grant Explores How Cells Remove Damaged Mitochondria — Opening New Possibilities Across Parkinson’s, Chronic Disease, Rare Disease, and Aging

Notified -...

Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder

Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder

Notified -...

Omantel Launches AI Centre of Excellence and AI Startups Program

Omantel Launches AI Centre of Excellence and AI Startups Program

Notified -...

nCino Announces Timing of its First Quarter Fiscal Year 2027 Financial Results Conference Call

nCino Announces Timing of its First Quarter Fiscal Year 2027 Financial Results Conference Call

Notified -...

Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock

Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock

Notified -...

1 ... 6 7 8 9 10 11 12 13 14 ... 1099
menu
menu